IUDs used for menstrual management, contraception in adolescents, young adults with disabilities
THURSDAY, July 23, 2020 (HealthDay News) — Data from a retrospective chart review suggest that levonorgestrel (LNG) intrauterine devices (IUDs) may be a useful option for menstrual management and contraception in adolescents and young adults with physical, intellectual, and developmental disabilities, according to a study published online July 23 in Pediatrics.
Beth I. Schwartz, M.D., from the Cincinnati Children’s Hospital Medical Center, and colleagues describe the characteristics and experiences of LNG IUD use in nulliparous children, adolescents, and young adults (aged 22 years and younger) with physical, intellectual, and developmental disabilities.
The researchers found that 185 LNG IUDs were placed in 159 patients with disability (mean age, 16.3 years). Only 4 percent of the patients had been sexually active. The IUDs were mainly inserted in the operating room (96 percent). IUD continuation rate was 95 and 73 percent at one and five years, respectively. Throughout the duration of IUD use, the rate of amenorrhea was about 60 percent among those with available follow-up data. Side effects and complications occurred in ≤3 percent.
“These data are very promising and should allow more accurate counseling of adolescents with special needs and their families about this highly effective, safe menstrual management and contraceptive method,” the authors write.
The study was supported by a grant from Bayer Healthcare.
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Drug Interactions Reducing Contraceptive Effectiveness Common in Epilepsy
Recommendations Issued for Use of Incretin-Based Meds in Pregnancy
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder
Nutritional Deficiencies Seen in Youth Taking GLP-1 Receptor Agonists
Eating More Ultraprocessed Foods Heightens Risk for Chronic Diseases
Mortality Lowest at Hemoglobin Concentrations Above WHO Thresholds
Oral Vitamin C Active in Clonal Cytopenia of Undetermined Significance
2009 to 2023 Saw Surge in Probiotic Supplement Use